Search Page

1

Cite

Share

Evoked responses in vitamin B12 deficiency.

Krumholz A, Weiss HD, Goldstein PJ, Harris KC. Krumholz A, et al. Among authors: weiss hd. Ann Neurol. 1981 Apr;9(4):407-9. doi: 10.1002/ana.410090417. Ann Neurol. 1981. PMID: 7224607

Cite

Share

2

Cite

Share

Evaluation of brainstem stroke using brainstem auditory evoked responses.

Stern BJ, Krumholz A, Weiss HD, Goldstein P, Harris KC. Stern BJ, et al. Among authors: weiss hd. Stroke. 1982 Sep-Oct;13(5):705-11. doi: 10.1161/01.str.13.5.705. Stroke. 1982. PMID: 7123605

Cite

Share

3

Cite

Share

"Pseudo-syndromes" associated with Parkinson disease, dementia, apathy, anxiety, and depression.

Weiss HD, Pontone GM. Weiss HD, et al. Neurol Clin Pract. 2019 Aug;9(4):354-359. doi: 10.1212/CPJ.0000000000000644. Neurol Clin Pract. 2019. PMID: 31583191 Free PMC article. Review.

Cite

Share

4

Cite

Share

Safety of dopamine agonists for treating restless legs syndrome.

Weiss HD. Weiss HD. Mov Disord. 2019 Jan;34(1):150. doi: 10.1002/mds.27573. Mov Disord. 2019. PMID: 30653731 No abstract available.

Cite

Share

5

Cite

Share

Clinical Pearls in Tremor and Other Hyperkinetic Movement Disorders.

Weiss HD. Weiss HD. Semin Neurol. 2016 Aug;36(4):335-41. doi: 10.1055/s-0036-1585098. Epub 2016 Sep 19. Semin Neurol. 2016. PMID: 27643901 Review.

Cite

Share

6

Cite

Share

Personality and reported quality of life in Parkinson's disease.

Pontone GM, Mari Z, Perepezko K, Weiss HD, Bassett SS. Pontone GM, et al. Among authors: weiss hd. Int J Geriatr Psychiatry. 2017 Mar;32(3):324-330. doi: 10.1002/gps.4475. Epub 2016 Apr 5. Int J Geriatr Psychiatry. 2017. PMID: 27059809 Free PMC article.

Cite

Share

7

Cite

Share

Dopamine receptor agonist drugs and impulse control disorders.

Weiss HD, Pontone GM. Weiss HD, et al. JAMA Intern Med. 2014 Dec;174(12):1935-7. doi: 10.1001/jamainternmed.2014.4097. JAMA Intern Med. 2014. PMID: 25329734 No abstract available.

Cite

Share

8

Cite

Share

Impulse control disorders and compulsive behaviors associated with dopaminergic therapies in Parkinson disease.

Weiss HD, Marsh L. Weiss HD, et al. Neurol Clin Pract. 2012 Dec;2(4):267-274. doi: 10.1212/CPJ.0b013e318278be9b. Neurol Clin Pract. 2012. PMID: 23634371 Free PMC article.

Cite

Share

9

Cite

Share

Pharmacologic treatment of anxiety disorders in Parkinson disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L. Pontone GM, et al. Among authors: weiss hd. Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. doi: 10.1016/j.jagp.2012.10.023. Epub 2013 Mar 29. Am J Geriatr Psychiatry. 2013. PMID: 23567419 Free PMC article.

Cite

Share

10

Cite

Share

Anxiety and self-perceived health status in Parkinson's disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L. Pontone GM, et al. Among authors: weiss hd. Parkinsonism Relat Disord. 2011 May;17(4):249-54. doi: 10.1016/j.parkreldis.2011.01.005. Epub 2011 Feb 2. Parkinsonism Relat Disord. 2011. PMID: 21292531 Free PMC article.

Cite

Share